TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients

2021 ◽  
Vol 159 ◽  
pp. 205-214
Author(s):  
Cecile Vicier ◽  
Patrick Sfumato ◽  
Nicolas Isambert ◽  
Florence Dalenc ◽  
Marie Robert ◽  
...  
2006 ◽  
Vol 17 (1) ◽  
pp. 79-84 ◽  
Author(s):  
F. Di Costanzo ◽  
S. Gasperoni ◽  
P. Papaldo ◽  
D. Bilancia ◽  
L. Manzione ◽  
...  

2007 ◽  
Vol 9 (4) ◽  
Author(s):  
Javier Silva ◽  
Vanesa García ◽  
José M García ◽  
Cristina Peña ◽  
Gemma Domínguez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document